Trends in Incidence of Infective Endocarditis at the Medical Center of Alkmaar

Overview

Journal Neth Heart J

Specialty Cardiology & Vascular Diseases

Date 2015 Sep 11

PMID 26353766

Citations 4

Authors

M M G Krul

A B A Vonk

J H Cornel

Affiliations

Soon will be listed here.

Abstract

Introduction: Infective endocarditis (IE) is a life-threatening illness with a high morbidity and mortality, and with a rise in incidence in patients with prosthetic valves and cardiac devices. Recently the Dutch guidelines of IE prophylaxis have been revised, limiting IE prophylaxis to the highest-risk population. The aim of the present study was to investigate the incidence of IE and its trend between 2008-2013 in a regional hospital in the Netherlands.

Methods: This is an observational descriptive study of all patients who were admitted with IE to the Medical Center of Alkmaar (MCA) from 1 January 2008 to 31 December 2013.

Results: A total of 89 patients with IE, including 7 patients (7.9 %) with a cardiac device IE (CDIE), were identified. In 2008 there were 8 patients with IE, this increased to 26 patients in 2013. Patients with a prosthetic valve IE increased from 25 % in 2008 to 34.6 % in 2013. This increase was not seen in patients with CDIE.

Conclusion: In the MCA we have observed an increase in patients with IE since 2010. This increase was in part attributable to prosthetic valve IE. A larger observational study is needed to investigate the increase of IE in the Netherlands.

Citing Articles

Distant embolisation in infective endocarditis: characteristics and outcomes.

Duffels M, Germans T, Bos-Schaap A, Drexhage O, Wagenaar J, van der Zant F Neth Heart J. 2023; 31(10):390-398.

PMID: 36995641 PMC: 10516844. DOI: 10.1007/s12471-023-01771-6.

Infective endocarditis in the Netherlands: current epidemiological profile and mortality : An analysis based on partial ESC EORP collected data.

El Kadi S, van den Buijs D, Meijers T, Gilbers M, Bekkers S, van Melle J Neth Heart J. 2020; 28(10):526-536.

PMID: 32504340 PMC: 7494701. DOI: 10.1007/s12471-020-01431-z.

Calculated initial parenteral treatment of bacterial infections: Bacterial endocarditis.

Dohmen P, Bodmann K, Graninger W, Shah P, Thallhammer F GMS Infect Dis. 2020; 8:Doc08.

PMID: 32373433 PMC: 7186797. DOI: 10.3205/id000052.

The changing landscape of infective endocarditis in the Netherlands.

Kietselaer B Neth Heart J. 2015; 23(11):546-7.

PMID: 26396086 PMC: 4608928. DOI: 10.1007/s12471-015-0752-z.

References

Renzulli A, Carozza A, Romano G, De Feo M, Della Corte A, Gregorio R . Recurrent infective endocarditis: a multivariate analysis of 21 years of experience. arenzul@tin.it. Ann Thorac Surg. 2001; 72(1):39-43. DOI: 10.1016/s0003-4975(01)02703-5. View

Dayer M, Jones S, Prendergast B, Baddour L, Lockhart P, Thornhill M . Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis. Lancet. 2014; 385(9974):1219-28. PMC: 5599216. DOI: 10.1016/S0140-6736(14)62007-9. View

DeSimone D, Tleyjeh I, Correa de Sa D, Anavekar N, Lahr B, Sohail M . Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association's endocarditis prevention guidelines. Circulation. 2012; 126(1):60-4. PMC: 3681201. DOI: 10.1161/CIRCULATIONAHA.112.095281. View

Stofmeel M, Kelder J, van Hemel N, Hooijschuur C, Dijk W, Grobbee D . [Implanted pacemakers in the Netherlands, 1984-1997; number, types and patient characteristics]. Ned Tijdschr Geneeskd. 2001; 145(26):1254-8. View

Mansur A, Dal Bo C, Fukushima J, Issa V, Grinberg M, Pomerantzeff P . Relapses, recurrences, valve replacements, and mortality during the long-term follow-up after infective endocarditis. Am Heart J. 2001; 141(1):78-86. DOI: 10.1067/mhj.2001.111952. View

Cabell C, Jollis J, Peterson G, Corey G, Anderson D, Sexton D . Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med. 2002; 162(1):90-4. DOI: 10.1001/archinte.162.1.90. View

Thornhill M, Dayer M, Forde J, Corey G, Chu V, Couper D . Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study. BMJ. 2011; 342:d2392. PMC: 3086390. DOI: 10.1136/bmj.d2392. View

Alagna L, Park L, Nicholson B, Keiger A, Strahilevitz J, Morris A . Repeat endocarditis: analysis of risk factors based on the International Collaboration on Endocarditis - Prospective Cohort Study. Clin Microbiol Infect. 2013; 20(6):566-75. DOI: 10.1111/1469-0691.12395. View

Rogers A, Schiller N . Impact of the first nine months of revised infective endocarditis prophylaxis guidelines at a university hospital: so far so good. J Am Soc Echocardiogr. 2008; 21(6):775. DOI: 10.1016/j.echo.2008.04.001. View

10.

Mylonakis E, Calderwood S . Infective endocarditis in adults. N Engl J Med. 2002; 345(18):1318-30. DOI: 10.1056/NEJMra010082. View

11.

Richey R, Wray D, Stokes T . Prophylaxis against infective endocarditis: summary of NICE guidance. BMJ. 2008; 336(7647):770-1. PMC: 2287232. DOI: 10.1136/bmj.39510.423148.AD. View

12.

Griffin M, Wilson W, Edwards W, OFallon W, Kurland L . Infective endocarditis. Olmsted County, Minnesota, 1950 through 1981. JAMA. 1985; 254(9):1199-202. DOI: 10.1001/jama.254.9.1199. View

13.

Baddour L, Wilson W, Bayer A, Fowler Jr V, Bolger A, Levison M . Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the.... Circulation. 2005; 111(23):e394-434. DOI: 10.1161/CIRCULATIONAHA.105.165564. View

14.

Wang A, Athan E, Pappas P, Fowler Jr V, Olaison L, Pare C . Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007; 297(12):1354-61. DOI: 10.1001/jama.297.12.1354. View

15.

van der Meer J, Thompson J, VALKENBURG H, Michel M . Epidemiology of bacterial endocarditis in The Netherlands. I. Patient characteristics. Arch Intern Med. 1992; 152(9):1863-8. DOI: 10.1001/archinte.152.9.1863. View

16.

Murdoch D, Corey G, Hoen B, Miro J, Fowler Jr V, Bayer A . Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009; 169(5):463-73. PMC: 3625651. DOI: 10.1001/archinternmed.2008.603. View

17.

Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I . Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the.... Eur Heart J. 2009; 30(19):2369-413. DOI: 10.1093/eurheartj/ehp285. View

18.

Sohail M, Uslan D, Khan A, Friedman P, Hayes D, Wilson W . Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007; 49(18):1851-9. DOI: 10.1016/j.jacc.2007.01.072. View

19.

Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, Briancon S . Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002; 288(1):75-81. DOI: 10.1001/jama.288.1.75. View

20.

Wilson W, Taubert K, Gewitz M, Lockhart P, Baddour L, Levison M . Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and.... J Am Dent Assoc. 2007; 138(6):739-45, 747-60. DOI: 10.14219/jada.archive.2007.0262. View